CryoLife Inc (NYSE:CRY)

During the Trading Day
9.98 -0.06 / -0.60%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.02 +0.0374 / +0.37%
Volume: 2.0K
Health Technology
Medical Specialties

Company Description

CryoLife, Inc. is a medical devices company, which preserved human cardiac and vascular tissues, surgical adhesives and sealants, cardiac lasers and implantable end-stage renal disease access grafts for the repair of complex cardiac and vascular reconstruction surgeries. It manufactures, distributes implantable living human tissues for use in cardiac and vascular surgeries. The company operates its business trough two segments: Medical Devices and Preservation Services. The Medical Devices segment includes marketing and distribution of BioGlue, BioFoam, PerClot, HemoStase and other. The Preservation Services segment preserves human cardiac and vascular tissue to implanting institutions throughout the United States, Canada and Europe. CryoLife was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.

Contact Information

CryoLife, Inc.
1655 Roberts Boulevard NW
Kennesaw Georgia 30144-3632
P:(770) 419-3355
Investor Relations:



Mutual fund holders33.54%
Other institutional26.26%
Individual stakeholders21.56%

Top Executives

James Patrick MackinPresident, Chief Executive Officer & Director
David Ashley LeeExecutive VP, Chief Operating & Financial Officer
Scott B. CappsVice President-Clinical Research
David C. GaleVice President-Research & Development
Timothy M. NejaVice President-Laboratory Operations

To view my watchlist

Not a member yet?

Sign up now for a free account